Compugen Ltd (CGEN) is a publicly traded Healthcare sector company. As of July 14, 2026, CGEN trades at $2.32 with a market cap of $226.06M and a P/E ratio of 0.00. CGEN moved -3.14% today. Year to date, CGEN is +55.41%; over the trailing twelve months it is +44.65%. Its 52-week range spans $1.13 to $3.24. Analyst consensus is strong buy with an average price target of $4.67. Rallies surfaces CGEN's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies AI research for CGEN combines live market data, fundamentals, news, analyst context, hedge fund holdings, politician trades, insider activity, and risk factors into a ticker-specific research workflow.
| Metric | Value |
|---|---|
| Price | $2.32 |
| Market Cap | $226.06M |
| P/E Ratio | 0.00 |
| EPS | $0.00 |
| Dividend Yield | 0.00% |
| 52-Week High | $3.24 |
| 52-Week Low | $1.13 |
| Volume | 228.51K |
| Avg Volume | 0 |
| Revenue (TTM) | $0 |
| Net Income | $0 |
| Gross Margin | 0.00% |
3 analysts cover CGEN: 0 strong buy, 3 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is strong buy. Average price target: $4.67.